MyFinsight
Home
Blog
About
Net income (loss)
$11,578K
(378.52%↑ Y/Y)
Purchases of property and
equipment
-$5K
Inventories
-$3,319K
(-130.42%↓ Y/Y)
Accrued liabilities
$2,236K
(286.18%↑ Y/Y)
Stock-based compensation
$1,468K
(-55.46%↓ Y/Y)
Depreciation and
amortization
$1,386K
(-31.32%↓ Y/Y)
Accounts payable
$921K
(-88.44%↓ Y/Y)
Inventory step-up
$650K
(-72.33%↓ Y/Y)
Excess and obsolete
inventory reserve
$354K
Debt discount
amortization and non-cash...
$160K
(-53.22%↓ Y/Y)
Non-cash lease expense
$36K
(20.00%↑ Y/Y)
Net cash from
operating activities
$7,255K
(-27.80%↓ Y/Y)
Net cash used in
investing activities
$5K
Canceled cashflow
$14,846K
Change in cash and cash
equivalents
$7,184K
(-31.21%↓ Y/Y)
Canceled cashflow
$76K
Accounts receivable
$11,478K
(26.24%↑ Y/Y)
Other non-current
assets and liabilities
$2,181K
(123.27%↑ Y/Y)
Prepaid expenses and
other assets
$1,015K
(251.04%↑ Y/Y)
Accrued medicaid
rebates
-$172K
(-101.84%↓ Y/Y)
Proceeds from stock
option exercises
$4,043K
Net cash from
financing activities
-$76K
(-119.29%↓ Y/Y)
Canceled cashflow
$4,043K
Repayment of long-term
debt
-$3,000K
Proceeds from shares
issued under the espp
-$1,119K
(-384.01%↓ Y/Y)
Back
Back
Cash Flow
Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON)
source: myfinsight.com